Publication | Closed Access

Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy

Glomerular DiseaseGlomerulonephritisRenal FunctionRenal DiseaseMedicineAdditive Antiproteinuric EffectIga GlomerulonephritisImmunologyChronic Kidney DiseaseEnzyme InhibitorDiabetic Kidney DiseaseKidney FailureIga NephropathyPharmacologyNephrologyKidney Research